Cargando…

Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities

Glioma is the most common intracranial malignant tumor, and the current main standard treatment option is a combination of tumor surgical resection, chemotherapy and radiotherapy. Due to the terribly poor five-year survival rate of patients with gliomas and the high recurrence rate of gliomas, some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yusong, Tian, Guopeng, Fang, Xiang, Bai, Shengwei, Yuan, Guoqiang, Pan, Yawen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686959/ https://www.ncbi.nlm.nih.gov/pubmed/36358495 http://dx.doi.org/10.3390/antiox11112123

Ejemplares similares

CASP4 can be a diagnostic biomarker and correlated with immune infiltrates in gliomas
por: Tian, Guopeng, et al.
Publicado: (2023)

Intracerebral hemorrhage associated with brucellosis: A case report
por: Luo, Yusong, et al.
Publicado: (2022)

Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma
por: Zhang, Gaosen, et al.
Publicado: (2022)

Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities
por: Wang, Hui, et al.
Publicado: (2023)

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
por: Wang, Kaikai, et al.
Publicado: (2022)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

The molecular mechanisms of ferroptosis and its role in glioma progression and treatment
por: Lu, Mengyang, et al.
Publicado: (2022)

Ferroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
por: Tabnak, Peyman, et al.
Publicado: (2021)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
por: You, Hongmei, et al.
Publicado: (2022)

Ferroptosis: An emerging therapeutic opportunity for cancer
por: Wang, Liyuan, et al.
Publicado: (2020)

Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities
por: Miao, Runyu, et al.
Publicado: (2023)

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
por: Zhuo, Shenghua, et al.
Publicado: (2022)

Ferroptosis sensitization in glioma: exploring the regulatory mechanism of SOAT1 and its therapeutic implications
por: Sun, Shicheng, et al.
Publicado: (2023)

Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy
por: Zhao, Yangting, et al.
Publicado: (2023)

The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases
por: Yao, Ying, et al.
Publicado: (2023)

OLFML2A Downregulation Inhibits Glioma Proliferation Through Suppression of Wnt/β-Catenin Signaling
por: Ma, Shize, et al.
Publicado: (2021)

Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
por: Haase, Santiago, et al.
Publicado: (2020)

Molecular mechanisms of ferroptosis and its role in cancer therapy
por: Xu, Tao, et al.
Publicado: (2019)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Efficacy of TTFields in high-grade gliomas: a protocol for systematic review and meta-analysis
por: Li, Xinlong, et al.
Publicado: (2023)

Molecular mechanisms of ferroptosis and relevance to inflammation
por: Deng, Liyan, et al.
Publicado: (2022)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
por: Daniel, Paul, et al.
Publicado: (2019)

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
por: Feng, Qi, et al.
Publicado: (2022)

The molecular mechanism of ferroptosis and its role in COPD
por: Meng, Dandan, et al.
Publicado: (2023)

Phytochemicals Targeting Ferroptosis: Therapeutic Opportunities and Prospects for Treating Breast Cancer
por: Zhao, Xinyi, et al.
Publicado: (2022)

Opportunities for Ferroptosis in Cancer Therapy
por: Fujihara, Kenji M., et al.
Publicado: (2021)

The Emerging Role of Ferroptosis in Sepsis, Opportunity or Challenge?
por: Huang, Qigang, et al.
Publicado: (2023)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

The Molecular Mechanisms of Ferroptosis and Its Role in Blood-Brain Barrier Dysfunction
por: Chen, Xiaoshu, et al.
Publicado: (2022)

Ferroptosis and its Role in Gastric Cancer
por: Gu, Renjun, et al.
Publicado: (2022)

Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease
por: Tao, Ningning, et al.
Publicado: (2020)

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
por: Zhao, Yan, et al.
Publicado: (2021)

PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
por: Sim, Hao-Wen, et al.
Publicado: (2022)

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
por: Hu, Zhifang, et al.
Publicado: (2020)

Ferroptosis in glioma treatment: Current situation, prospects and drug applications
por: Zhou, Yuhang, et al.
Publicado: (2022)

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach
por: Chen, Heshu, et al.
Publicado: (2022)

Mechanisms and regulations of ferroptosis
por: Zhang, Xu-Dong, et al.
Publicado: (2023)

Molecular mechanisms of ferroptosis and its antitumor applications in natural products: Ferroptosis and applications in natural products
por: Yu, Dianping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4v91jb061cgui9n6f57oh6mo16